AKT1 and ovarian carcinoma: In summary, this study demonstrates, for the first time, the reversal MDR potential of GFW for ovarian cancer in vitro and in vivo by inhibiting the protein expression and function of P-gp, which may act through the inactivation of the PI3K/AKT/mTOR signalling pathway.